|
1
|
Andreassen PR, Palmer DK, Wener MH and
Margolis RL: Telophase disc: A new mammalian mitotic organelle that
bisects telophase cells with a possible function in cytokinesis. J
Cell Sci. 99:523–534. 1991.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Carmena M, Wheelock M, Funabiki H and
Earnshaw WC: The chromosomal passenger complex (CPC): From easy
rider to the godfather of mitosis. Nat Rev Mol Cell Biol.
13:789–803. 2012.PubMed/NCBI View
Article : Google Scholar
|
|
3
|
Cooke CA, Heck MM and Earnshaw WC: The
inner centromere protein (INCENP) antigens: Movement from inner
centromere to midbody during mitosis. J Cell Biol. 105:2053–2067.
1987.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Papini D, Langemeyer L, Abad MA, Kerr A,
Samejima I, Eyers PA, Jeyaprakash AA, Higgins JM, Barr FA and
Earnshaw WC: TD-60 links RalA GTPase function to the CPC in
mitosis. Nat Commun. 6(7678)2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Song C, Liang L, Jin Y, Li Y, Liu Y, Guo
L, Wu C, Yun CH and Yin Y: RCC2 is a novel p53 target in
suppressing metastasis. Oncogene. 37:8–17. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Matsuo M, Nakada C, Tsukamoto Y, Noguchi
T, Uchida T, Hijiya N, Matsuura K and Moriyama M: MiR-29c is
downregulated in gastric carcinomas and regulates cell
proliferation by targeting RCC2. Mol Cancer. 12(15)2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Yi JM, Kang EJ, Kwon HM, Bae JH, Kang K,
Ahuja N and Yang K: Epigenetically altered miR-1247 functions as a
tumor suppressor in pancreatic cancer. Oncotarget. 8:26600–26612.
2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Buranjiang G, Kuerban R, Abuduwanke A, Li
X and Kuerban G: MicroRNA-331-3p inhibits proliferation and
metastasis of ovarian cancer by targeting RCC2. Arch Med Sci.
15:1520–1529. 2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Chen Z, Wu W, Huang Y, Xie L, Li Y, Chen
H, Li W, Yin D and Hu K: RCC2 promotes breast cancer progression
through regulation of Wnt signaling and inducing EMT. J Cancer.
10:6837–6847. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Rendleman J, Shang S, Dominianni C,
Shields JF, Scanlon P, Adaniel C, Desrichard A, Ma M, Shapiro R,
Berman R, et al: Melanoma risk loci as determinants of melanoma
recurrence and survival. J Transl Med. 11(279)2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Bruun J, Kolberg M, Ahlquist TC, Røyrvik
EC, Nome T, Leithe E, Lind GE, Merok MA, Rognum TO, Bjørkøy G, et
al: Regulator of chromosome condensation 2 identifies high-risk
patients within both major phenotypes of colorectal cancer. Clin
Cancer Res. 21:3759–3770. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hammond SM and Sharpless NE: HMGA2,
microRNAs, and stem cell aging. Cell. 135:1013–1016.
2008.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Young AR and Narita M: Oncogenic HMGA2:
Short or small? Genes Dev. 21:1005–1009. 2007.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zhang S, Mo Q and Wang X: Oncological role
of HMGA2 (Review). Int J Oncol. 55:775–788. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wang X, Wang J and Wu J: Emerging roles
for HMGA2 in colorectal cancer. Transl Oncol.
14(100894)2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wang Y, Hu L, Wang J, Li X, Sahengbieke S,
Wu J and Lai M: HMGA2 promotes intestinal tumorigenesis by
facilitating MDM2-mediated ubiquitination and degradation of p53. J
Pathol. 246:508–518. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Li L, Shao M, Peng P, Yang C, Song S, Duan
F, Jia D, Zhang M, Zhao J, Zhao R, et al: High expression of GFAT1
predicts unfavorable prognosis in patients with hepatocellular
carcinoma. Oncotarget. 8:19205–19217. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q,
Li B and Liu XS: TIMER2.0 for analysis of tumor-infiltrating immune
cells. Nucleic Acids Res. 48:W509–W514. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wu J, Wang Y, Xu X, Cao H, Sahengbieke S,
Sheng H, Huang Q and Lai M: Transcriptional activation of FN1 and
IL11 by HMGA2 promotes the malignant behavior of colorectal cancer.
Carcinogenesis. 37:511–521. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Guo K, Zhao C, Lang B, Wang H, Zheng H and
Zhang F: Regulator of chromosome condensation 2 modulates cell
cycle progression, tumorigenesis, and therapeutic resistance. Front
Mol Biosci. 7(620973)2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Lin H, Zhang X, Feng N, Wang R, Zhang W,
Deng X, Wang Y, Yu X, Ye X, Li L, et al: LncRNA LCPAT1 mediates
smoking/ particulate matter 2.5-induced cell autophagy and
epithelial- mesenchymal transition in lung cancer cells via RCC2.
Cell Physiol Biochem. 47:1244–1258. 2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Pang B, Wu N, Guan R, Pang L, Li X, Li S,
Tang L, Guo Y, Chen J, Sun D, et al: Overexpression of RCC2
enhances cell motility and promotes tumor metastasis in lung
adenocarcinoma by inducing epithelial-mesenchymal transition. Clin
Cancer Res. 23:5598–5610. 2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Vrînceanu D, Dumitru M, Ştefan AA,
Mogoantă CA and Sajin M: Giant pleomorphic sarcoma of the tongue
base-a cured clinical case report and literature review. Rom J
Morphol Embryo. 61:1323–1327. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Giannakis M, Hodis E, Jasmine Mu X,
Yamauchi M, Rosenbluh J, Cibulskis K, Saksena G, Lawrence MS, Qian
ZR, Nishihara R, et al: RNF43 is frequently mutated in colorectal
and endometrial cancers. Nat Genet. 46:1264–1266. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
25
|
Humphries JD, Byron A, Bass MD, Craig SE,
Pinney JW, Knight D and Humphries MJ: Proteomic analysis of
integrin-associated complexes identifies RCC2 as a dual regulator
of Rac1 and Arf6. Sci Signal. 2(ra51)2009.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Yang WH, Lan HY, Huang CH, Tai SK, Tzeng
CH, Kao SY, Wu KJ, Hung MC and Yang MH: RAC1 activation mediates
Twist1-induced cancer cell migration. Nat Cell Biol. 14:366–374.
2012.PubMed/NCBI View
Article : Google Scholar
|
|
27
|
Valderrama F and Ridley AJ: Getting
invasive with GEP100 and Arf6. Nat Cell Biol. 10:16–18.
2008.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Fedele M, Battista S, Kenyon L,
Baldassarre G, Fidanza V, Klein-Szanto AJ, Parlow AF, Visone R,
Pierantoni GM and Outwater E: Overexpression of the HMGA2 gene in
transgenic mice leads to the onset of pituitary adenomas. Oncogene.
21:3190–3198. 2002.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Parisi S, Piscitelli S, Passaro F and
Russo T: HMGA proteins in stemness and differentiation of embryonic
and adult stem cells. Int J Mol Sci. 21:3190–3198. 2020.PubMed/NCBI View Article : Google Scholar
|
